CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business at two upcoming investor conferences:
The 14th Annual BIO CEO & Investor Conference in New York City. Dr. Berger’s presentation is on Monday, February 13 at 9:00 a.m. (ET)
The 14th Annual BIO CEO & Investor Conference in New York City. Dr. Berger’s presentation is on Monday, February 13 at 9:00 a.m. (ET)
